Vajdi, Mahdi
Khorvash, Fariborz
Rouhani, Mohammad Hossein
Ghavami, Abed
Clark, Cain C. T.
Askari, Gholamreza http://orcid.org/0000-0003-1194-9687
Funding for this research was provided by:
Isfahan University of Medical Sciences
Article History
Received: 1 August 2023
Accepted: 31 October 2023
First Online: 11 November 2023
Declarations
:
: The study protocol is drafted in accordance with the SPIRIT checklist and is approved by the Medical Ethics Committee of Isfahan University of Medical Sciences, Isfahan, Iran (ID: IR.MUI.RESEARCH.REC. 1401.416). The current trial is registered at the Iranian Registry of Clinical (ID: IRCT20121216011763N58). The current trial will be conducted in compliance with the Declaration of Helsinki. At the first visit (-W<sub>1</sub>), we will explain to each volunteer the risk and benefit of this trial. We will reassure the volunteers about the confidentiality of their information and expressing the results to them in general at the end of the study and also will answer to their questions regarding this study. Finally, we will publish the research results for the use of other researchers without mentioning the names and personal details of the participants at the end of the study. Written informed consent will be obtained from all volunteers before trial entry. This intervention will not interfere with the routine treatment of patients with migraine.
: This paper does not contain any personal data.
: The authors declare that they have no competing interests.